APA (7th ed.) Citation

Hochman, M. J., Ruppert, A. S., Huang, Y., Mims, A., Borate, U., Swords, R., . . . Blum, W. (2026, April). Phase Ib/II trial of anti-CD33 monoclonal antibody BI 836858 and azacitidine in previously untreated older acute myeloid leukemia patients: Beat AML S2 sub-study results. Haematologica.

Chicago Style (17th ed.) Citation

Hochman, Michael J., et al. "Phase Ib/II Trial of Anti-CD33 Monoclonal Antibody BI 836858 and Azacitidine in Previously Untreated Older Acute Myeloid Leukemia Patients: Beat AML S2 Sub-study Results." Haematologica Apr. 2026.

MLA (9th ed.) Citation

Hochman, Michael J., et al. "Phase Ib/II Trial of Anti-CD33 Monoclonal Antibody BI 836858 and Azacitidine in Previously Untreated Older Acute Myeloid Leukemia Patients: Beat AML S2 Sub-study Results." Haematologica, Apr. 2026.